| ebi-pharm ag - Neurexan, Tabletten | | 62242 | | 01 | | Neurexan | | Tabletten | | N05CZ | | Sedativa, Homöopathika | | 18.06.2012 | | |
| | Composition | | avena sativa (HAB) D2 0.6 mg, coffea arabica (HAB) D12 0.6 mg, passiflora incarnata (HAB) D2 0.6 mg, zincum isovalerianicum (HAB) D4 (HAB 5a) 0.6 mg, lactosum monohydricum 300.0 mg, magnesii stearas, pro compresso 301.5 mg. | | Packungsbestandteile | | Tablets | | | | Active Agent | Dose |
|---|
| Avena Sativa (Hab) D2 | 0.6 mg | | Coffea Arabica (Hab) D12 | 0.6 mg | | Passiflora Incarnata (Hab) D2 | 0.6 mg | | Zincum Isovalerianicum (Hab) D4 (Hab 5A) | 0.6 mg |
| | | | Inactive agents | Dose |
|---|
| Lactose Monohydrate | 300 mg | | Magnesii Stearas | | | Pro Compresso | 301.5 mg |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 50 Tablet(s) | PR | PR | D | | Yes | | 002 | 250 Tablet(s) | PR | PR | D | | Yes |
|
|
